AIkido Pharma, Inc.
(NASDAQ : AIKI)

( )
AIKI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.21%161.910.0%$1387.78m
NVAXNovavax, Inc. -2.57%221.5080.0%$650.79m
AMGNAmgen, Inc. 0.10%255.971.3%$554.37m
SNSSSunesis Pharmaceuticals, Inc. -5.63%7.550.7%$527.77m
ILMNIllumina, Inc. 1.30%404.183.5%$527.33m
REGNRegeneron Pharmaceuticals, Inc. -0.58%499.692.7%$447.00m
GILDGilead Sciences, Inc. -1.38%65.951.0%$437.06m
VRTXVertex Pharmaceuticals, Inc. -0.10%219.181.9%$383.57m
ALXNAlexion Pharmaceuticals, Inc. 1.09%165.472.0%$360.29m
BNTXBioNTech SE -1.36%149.480.0%$336.51m
BIIBBiogen, Inc. -0.47%269.051.7%$246.78m
NBIXNeurocrine Biosciences, Inc. -1.79%94.854.9%$180.78m
EXASEXACT Sciences Corp. -1.93%127.5318.4%$168.47m
CRSPCRISPR Therapeutics AG -2.97%115.040.6%$158.56m
SGENSeagen Inc. -1.02%144.015.8%$140.14m

Company Profile

AIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.